System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. [electronic resource]
Producer: 20110202Description: 4572-82 p. digitalISSN:- 1557-3265
- Antineoplastic Agents -- therapeutic use
- Aurora Kinase B
- Aurora Kinases
- Chromatography, Liquid -- methods
- Drug Evaluation, Preclinical
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Humans
- Microarray Analysis
- Molecular Targeted Therapy -- methods
- Neoplastic Stem Cells -- metabolism
- Neuroblastoma -- drug therapy
- Protein Kinase Inhibitors -- therapeutic use
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- RNA, Small Interfering -- pharmacology
- Systems Biology -- methods
- Tandem Mass Spectrometry -- methods
- Therapies, Investigational -- methods
- Validation Studies as Topic
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.